FTC Victory in Edwards Lifesciences Merger: 4 Key Takeaways for Life Sciences Deals

Tony Chan, Craig Falls, Eric Hochstadt
Orrick, Herrington & Sutcliffe LLP
Contact
LinkedIn
Facebook
X
Send
Embed

The Federal Trade Commission's recent victory blocking Edwards Lifesciences Corp.'s proposed acquisition of JenaValve Technology Inc. offers lessons for parties advancing future transactions for innovators of medical devices, in the life sciences and any industry heavy in research and development, while also highlighting risks for parties negotiating mergers and acquisitions

Please see full publication below for more information.

View PDF
Download PDF [209KB]
Email
Report

LOADING PDF: If there are any problems, click here to download the file.
Send Report

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations. Attorney Advertising.

© Orrick, Herrington & Sutcliffe LLP

Written by:

Orrick, Herrington & Sutcliffe LLP
Orrick, Herrington & Sutcliffe LLP
Contact
more
less

What do you want from legal thought leadership?

Please take our short survey – your perspective helps to shape how firms create relevant, useful content that addresses your needs:

Orrick, Herrington & Sutcliffe LLP on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign Up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide